Literature DB >> 28629898

Alpha-lipoic acid supplement in obesity treatment: A systematic review and meta-analysis of clinical trials.

Nazli Namazi1, Bagher Larijani2, Leila Azadbakht3.   

Abstract

BACKGROUND & AIMS: Previous studies have supported positive roles of antioxidant supplements on weight-loss. One antioxidant supplement is Alpha-lipoic acid. However, recommending ALA as an anti-obesity supplement remains controversial. Accordingly, the purpose of the present study was to perform a meta-analysis on the effects of ALA supplement on anthropometric indices among adult subjects.
METHODS: We searched five electronic databases till September 2016. Placebo-controlled clinical trials were included. Weighted Mean Difference (WMD) was pooled using a random-effects model.
RESULTS: Findings of 12 included trials indicated that ALA supplement reduced body weight (WMD: -0.69 kg; 95% CI: -1.27, -0.10; I2 = 0%) and BMI (WMD: -0.38 kg/m2; 95% CI: -0.53, -0.24; I2 = 0%) significantly compared to the placebo group. However, its effects on Waist Circumference (WC) was not significant (WMD: -0.30 cm; 95% CI: -1.18, 0.58; I2 = 17.8%). Stratification by health status indicated that ALA decreased WC in unhealthy subjects (WMD: -2.00 cm; 95% CI: -4.19, 0.19; I2 = 1.3%) more than healthy individuals (0.03 cm; 95% CI: -0.69, 0.75; I2 = 0%).
CONCLUSIONS: The present study revealed that supplementation with ALA slightly but significantly decreased body weight and BMI. Safe dosage for ALA is up to 1200 mg/day. However, it seems that ALA cannot be cost-effective. Further studies are needed to clarify the effects of ALA on metabolic parameter in unhealthy obese individuals.
Copyright © 2017 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Alpha-lipoic acid; Obesity; Overweight; Weight-loss

Mesh:

Substances:

Year:  2017        PMID: 28629898     DOI: 10.1016/j.clnu.2017.06.002

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  13 in total

1.  Combining a β3 adrenergic receptor agonist with alpha-lipoic acid reduces inflammation in male mice with diet-induced obesity.

Authors:  Zahraa Abdul Sater; Cheryl Cero; Anne E Pierce; Hannah J Lea; Houssein Abdul Sater; Kenneth Y Zhu; Naili Liu; Yinyan Ma; Oksana Gavrilova; Aaron M Cypess
Journal:  Obesity (Silver Spring)       Date:  2021-11-25       Impact factor: 9.298

2.  New insights into immunomodulation via overexpressing lipoic acid synthase as a therapeutic potential to reduce atherosclerosis.

Authors:  Shaomin Tian; Jun Nakamura; Sylvia Hiller; Stephen Simington; Darcy W Holley; Roberto Mota; Monte S Willis; Scott J Bultman; J Christopher Luft; Joseph M DeSimone; Zhenquan Jia; Nobuyo Maeda; Xianwen Yi
Journal:  Vascul Pharmacol       Date:  2020-08-01       Impact factor: 5.773

3.  A Randomized Controlled Trial of Long-Term (R)-α-Lipoic Acid Supplementation Promotes Weight Loss in Overweight or Obese Adults without Altering Baseline Elevated Plasma Triglyceride Concentrations.

Authors:  Gerd Bobe; Alexander J Michels; Wei-Jian Zhang; Jonathan Q Purnell; Clive Woffendin; Cliff Pereira; Joseph A Vita; Nicholas O Thomas; Maret G Traber; Balz Frei; Tory M Hagen
Journal:  J Nutr       Date:  2020-09-01       Impact factor: 4.798

4.  Alpha-lipoic acid effect on leptin and adiponectin concentrations: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Fahimeh Haghighatdoost; Ali Gholami; Mitra Hariri
Journal:  Eur J Clin Pharmacol       Date:  2020-02-10       Impact factor: 2.953

Review 5.  Diabetes Treatment in the Elderly: Incorporating Geriatrics, Technology, and Functional Medicine.

Authors:  Willy Marcos Valencia; Diana Botros; Maria Vera-Nunez; Stuti Dang
Journal:  Curr Diab Rep       Date:  2018-09-05       Impact factor: 4.810

6.  The Beneficial Effects of Alpha Lipoic Acid Supplementation on Lp-PLA2 Mass and Its Distribution between HDL and apoB-Containing Lipoproteins in Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Nima Baziar; Ensieh Nasli-Esfahani; Kurosh Djafarian; Mostafa Qorbani; Mehdi Hedayati; Mahshid Abd Mishani; Zeinab Faghfoori; Najva Ahmaripour; Saeed Hosseini
Journal:  Oxid Med Cell Longev       Date:  2020-03-09       Impact factor: 6.543

7.  Reduced Graphene Oxide Sheets as Inhibitors of the Photochemical Reactions of α-Lipoic Acid in the Presence of Ag and Au Nanoparticles.

Authors:  N'ghaya Toulbe; Malvina S Stroe; Monica Daescu; Radu Cercel; Alin Mogos; Daniela Dragoman; Marcela Socol; Ionel Mercioniu; Mihaela Baibarac
Journal:  Nanomaterials (Basel)       Date:  2020-11-11       Impact factor: 5.076

8.  Alpha lipoic acid attenuates ER stress and improves glucose uptake through DNAJB3 cochaperone.

Authors:  Abdoulaye Diane; Naela Mahmoud; Ilham Bensmail; Namat Khattab; Hanan A Abunada; Mohammed Dehbi
Journal:  Sci Rep       Date:  2020-11-24       Impact factor: 4.379

9.  Untargeted metabolomic on urine samples after α-lipoic acid and/or eicosapentaenoic acid supplementation in healthy overweight/obese women.

Authors:  Ana Romo-Hualde; Ana E Huerta; Carlos J González-Navarro; Omar Ramos-López; María J Moreno-Aliaga; J Alfredo Martínez
Journal:  Lipids Health Dis       Date:  2018-05-09       Impact factor: 3.876

10.  Prevalence of and attitudes towards complementary therapy use for weight after breast cancer in Australia: a national survey.

Authors:  Carolyn Ee; Adele Elizabeth Cave; Dhevaksha Naidoo; John Boyages
Journal:  BMC Complement Altern Med       Date:  2019-11-21       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.